Samrudh Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 21-06-2024
- Paid Up Capital ₹ 6.20 M
as on 21-06-2024
- Company Age 33 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 101.44 Cr
as on 21-06-2024
- Revenue 11.55%
(FY 2022)
- Profit 272.00%
(FY 2022)
- Ebitda 42.16%
(FY 2022)
- Net Worth 1.54%
(FY 2022)
- Total Assets -7.26%
(FY 2022)
About Samrudh Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.20 M.
The company currently has active open charges totaling ₹101.44 Cr.
Mohan Jain, Manish Jain, Sharad Sheth, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239MH1991PTC061667
- Company No.
061667
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 1991
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Samrudh Pharmaceuticals Private Limited offer?
Samrudh Pharmaceuticals Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Samrudh Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Jain  | Managing Director | 26-Mar-2018 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manish Jain | Director | 08-Jan-2021 | Current |
| Alok Sheth | Whole-Time Director | 01-Apr-1996 | Current |
| Sharad Sheth | Whole-Time Director | 22-Apr-1992 | Current |
Financial Performance and Corporate Structure Insights of Samrudh Pharmaceuticals.
Samrudh Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.55% increase. The company also saw a substantial improvement in profitability, with a 272% increase in profit. The company's net worth moved up by a moderate rise of 1.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samrudh Pharmaceuticals?
In 2021, Samrudh Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Mac-Chem Products (India) Private LimitedActive 33 years 4 monthsMohan Jain and Manish Jain are mutual person
Samrudh Healthcare Private LimitedActive 27 years 1 monthSharad Sheth and Alok Sheth are mutual person
- Samrudh Pharmacare Private LimitedActive 29 years 7 months
Sharad Sheth and Alok Sheth are mutual person
Miracalus Pharma Private LimitedActive 17 years 7 monthsMohan Jain and Manish Jain are mutual person
Naprod Life Sciences Private LimitedActive 34 years 4 monthsMohan Jain and Manish Jain are mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 06 Jul 2012 | ₹1.49 M | Open |
Bank Of India Creation Date: 31 Aug 2010 | ₹1.00 Cr | Open |
Bank Of India Creation Date: 06 Jul 2009 | ₹3.00 Cr | Open |
How Many Employees Work at Samrudh Pharmaceuticals?
Samrudh Pharmaceuticals has a workforce of 328 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samrudh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samrudh Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
